Insulet Management to Present at Bernstein Healthcare Forum
Event summary
- Insulet Corporation (NASDAQ: PODD) will present at Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum on September 24, 2026, at 12:30 p.m. ET.
- The presentation will be available via live webcast and replay on Insulet’s Investor Relations website.
- Insulet is a global leader in tubeless insulin pump technology, known for its Omnipod® brand products.
- The company’s Omnipod 5 Automated Insulin Delivery System integrates with continuous glucose monitors for automated insulin management.
The big picture
Insulet’s participation in the Bernstein Healthcare Forum underscores its role as a key player in the diabetes management space. The event provides a platform for the company to highlight its innovative technology and strategic direction amid increasing competition in the medical device sector. The integration of its Omnipod 5 system with continuous glucose monitors positions Insulet at the forefront of automated insulin delivery solutions.
What we're watching
- Strategic Positioning
- How Insulet’s presentation will emphasize its competitive edge in the tubeless insulin pump market.
- Market Expansion
- Whether Insulet will discuss plans to expand its Omnipod technology platform into other therapeutic areas.
- Investor Sentiment
- The impact of the presentation on investor confidence and potential stock movements.
Related topics